Nomad Power Solutions, Inc. LIXT 深 沪
等待开盘 07-06 09:30:00 美东时间
7.21
-0.460
-6.00%
华盛通- 最 高7.99
- 今 开7.95
- 成交量 61.51万股
- 最 低 7.00
- 昨 收 7.67
- 总市值 12.54万
- 52周最高 8.3773
- 市盈率 静 --
- 换手率 3537.57%
- 52周最低 2.36
- 委 比 -66.67%
- 总股本 1.74万
- 历史最高 71.90
- 量 比 0.90
- 振 幅 12.91%
- 历史最低 0.64
- 每 手 1
- 风险率 1.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LIXTE Biotechnology Set To Join Russell Microcap, Effective June 26
LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), today announced its inclusion in the Russell Microcap® Index, effective after the close of the U.S. equity markets on June 26, 2026, as part of the annual Russell U.S. Indexes reconstitution. The reconstituted indexes will ...
06-26 20:31
LIXTE Issues Update On NOMAD Acquisition; Loans $6.5M Pre‑Closing To Fund Order Backlog And Working Capital Needs; Combined Firm To Be Renamed NOMAD Power Solutions
Company to Loan $6.5 Million Prior to Closing to Fund Order Backlog and Working Capital Needs – Combined Company to be Renamed NOMAD Power Solutions, Inc. and Trade Under a New Ticker Symbol BOCA RATON, Fla. & WATERBURY, Vt., June 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (NASD...
06-18 20:38
LIXTE Biotechnology To Seek Strategic Acquisition Partner For Its Clinical Stage Pharmaceutical And Med-Tech Business
LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), today announced its strategic transformation into an AI energy infrastructure equipment & services platform focused on meeting the rapidly
06-01 20:52
Lixte Biotech Hldgs Q1 EPS $(0.18) Up From $(0.29) YoY
Lixte Biotech Hldgs (NASDAQ:LIXT) reported quarterly losses of $(0.18) per share. This is a 37.93 percent increase over losses of $(0.29) per share from the same period last year.
05-15 05:17
Lixte Biotech Hldgs Q4 EPS $(0.34) Down From $(0.27) YoY
Lixte Biotech Hldgs (NASDAQ:LIXT) reported quarterly losses of $(0.34) per share. This is a 25.93 percent decrease over losses of $(0.27) per share from the same period last year.
04-01 06:52
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline
Austin, Texas, United States, March 10th, 2026, FinanceWire LIXTE Biotechnology...
03-11 00:00
LIXTE Announces An Expansion Of Its Collaboration With The University Of Texas MD Anderson Cancer Center And Pharmaceutical Manufacturer GSK On An Ongoing Clinical Trial Evaluating Its Proprietary Compound LB-100 In Combination With GSK's Dostarlimab For The Treatment Of Ovarian Clear Cell Cancer
LIXTE Biotechnology Holdings (NASDAQ:LIXT) announced an expansion of its collaboration with The University of Texas MD Anderson Cancer Center and pharmaceutical manufacturer GSK on an ongoing clinical trial
01-09 05:02
Lixte Biotechnology Enters Share Exchange Agreement, Swapping 2,700 Series C Preferred Shares For 700,000 Common Shares And ~20% Of Outstanding Shares For Subsidiary Liora Technologies Europe
On December 30, 2025, Lixte Biotechnology Holdings, Inc., a Delaware corporation (the "Company"), entered into a Share Exchange Agreement (the "Agreement") with Orbit Capital Inc., a Cayman Islands corporation
01-01 05:05
Lixte Biotechnology Announces New Registered Direct Offering
Lixte Biotechnology Holdings ( ($LIXT) ) has shared an announcement. On Decembe...
2025-12-23 06:48
Lixte Biotechnology Holdings shares are trading lower after the company announced it commenced a $4.3 million common stock offering at $4.09 per common unit.
Lixte Biotechnology Holdings shares are trading lower after the company announc...
2025-12-18 22:26
